Brief: Auris Medical Announces Randomization Of First Patient In Am-125 Phase 2 Trial In Acute Vertigo

Altamira Therapeutics

30/07/2019 13:58

July 30 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN
AM-125
PHASE 2 TRIAL IN ACUTE VERTIGO
    * AURIS MEDICAL - TRAVERS TRIAL WILL ENROLL 138 PATIENTS WHO
SUFFER FROM ACUTE VERTIGO FOLLOWING SURGICAL REMOVAL OF A
VESTIBULAR SCHWANNOMA
    * AURIS MEDICAL HOLDING LTD -  TWO DOSES WILL BE SELECTED
AND
TESTED IN AN ESTIMATED 72 PATIENTS IN PART B OF TRAVERS TRIAL

Source text for Eikon:  ID:nGNXbwNw58 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))